[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"remote-monitoring\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:remote-monitoring":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,43,75,104,134,160,206,233,256],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100644990","oncologic-timely-palliative-care-and-remote-monitoring-with-electronic-assessments-and-telehealth-on-target-100644990",false,"NCT07674797","Oncologic Timely Palliative Care And Remote Monitoring With Electronic Assessments And Telehealth (ON-TARGET)","Eligibility Criteria\n\n* Age ≥ 18\n* Outpatients who are within 12 weeks of diagnosis of metastatic solid tumors and seen by one of the participating medical oncologists\n* Eastern Cooperative Oncology Group Performance Status 0.2\n* Able to speak English or Spanish\n\nExclusion Criteria:\n\n. Cognitive impairment in the opinion of the oncologist necessitating need for a surrogate decision making.\n\n• Previously seen by SPC team at UT MD Anderson","ALL","18 Years",{"count":18,"type":19},300,"ESTIMATED","INTERVENTIONAL",[22],"NA","To examine how we can provide supportive care for patients with advanced cancer better tailored to their needs",[25,26,27,28,29],"Oncologic","Palliative Care","Remote Monitoring","Electronic Assessments","Telehealth","NOT_YET_RECRUITING","2026-06-24",{"date":33,"type":34},"2026-06-30","ACTUAL",{"date":36,"type":19},"2026-11-22",{"date":38,"type":19},"2034-06-30",{"name":40,"class":41},"M.D. Anderson Cancer Center","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":20,"phases":53,"briefSummary":54,"conditions":55,"keywords":60,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":74},"100633062","remote-ecg-monitoring-post-tavi-100633062","NCT07521800","Remote ECG Monitoring Post TAVI","Remote ECG Monitoring as a Diagnostic Tool for Therapeutic Strategies After Transcatheter Aortic Valve Replacement: Rationale and Design of the DRAGON-TAVI Trial.","DRAGON-TAVI","Inclusion Criteria:\n\n* Patient age over 18 years old\n* Severe aortic stenosis\n* Moderate or high cardiovascular risk based on current ESC Guidelines \"Heart Team\" qualification for TAVI\n* Written informed consent of the patient for participation in the study\n\nExclusion Criteria:\n\n* History of atrial fibrillation or atrial flutter\n* Previously known conduction disturbances\\*\\*\n* Presence of: pacemaker, CRT-P, ICD, CRT-D before or after TAVI\n* Ischaemic stroke, TIA, MI or heart surgery within 1 month before TAVI qualification\n* Haemorrhagic stroke within 1 year before TAVI qualification\n* Chronic immunosuppressive therapy\n* Comorbidities (e.g. drug addiction, alcohol abuse, emotional\u002Fmental disorders) which do not allow safe participation in the study",{"count":52,"type":19},250,[22],"The DRAGON TAVI study is a multicenter, prospective, open, randomised trial, which will enrol 250 patients, randomized 1:1 to the study group (continuous 30-day ECG monitoring with visits triggered by ECG findings) and standard care (ie. control group, which will receive the standard post op 24-48h ECG monitoring and a regular follow-up visit with standard ECG within 30 days). The duration of the study is 12 months ± 1 month.",[56,27,57,58,59],"TAVI(Transcatheter Aortic Valve Implantation)","Arrythmia","Atrial Fibrillation (AF)","Atrioventricular Block",[61,62,63],"TAVI","ECG","Monitoring","RECRUITING","2026-04-07",{"date":67,"type":34},"2026-04-13",{"date":69,"type":34},"2023-12-01",{"date":71,"type":19},"2028-02-01",{"name":73,"class":41},"Medical University of Silesia",4,{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":15,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":20,"phases":86,"briefSummary":87,"conditions":88,"keywords":4,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":74},"100495559","mobile-video-directly-observed-therapy-dot-for-immunosuppression-medication-adherence-in-adolescent-heart-transplant-recipients-100495559","NCT05732779","Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients","Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients: Enhancing Technological Innovation and Strengthening the Role of Small Businesses in Meeting Needs of Adolescent Organ Transplant","Inclusion Criteria:\n\n* Eligible participants are 10-21 years of age\n* Have received a heart transplant and are followed participating pediatric heart transplant centers\n* English-speaking or Spanish-speaking\n* Own a smart-phone or have access to the mobile app through other devices\n* Are willing to receive information through it\n* Have a MLVI score of greater than 2.0 over the last year\n\nExclusion Criteria:\n\n• Those with cognitive impairments will not be eligible for enrollment due to inability to provide informed assent","10 Years","21 Years",{"count":85,"type":19},100,[22],"We will conduct a two-group randomized controlled trial to examine the eMocha DOT intervention with pediatric HT recipients.In this population, medication nonadherence remains a primary cause of late acute rejection (LAR) episodes, increased number of hospitalizations, graft failure, and patient mortality. Herein, we propose an innovative approach to promote medication adherence and improve patient and graft outcomes.",[89,90,91,92,93,27,94],"Heart Transplant Rejection","Immune Suppression","Pediatric Heart Transplant","Medication Nonadherence","Health Behavior","Patient Engagement","2026-02-24",{"date":97,"type":34},"2026-02-27",{"date":99,"type":34},"2024-10-01",{"date":101,"type":19},"2027-05-01",{"name":103,"class":41},"University of Florida",{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":11,"sex":15,"minAge":111,"maxAge":112,"enrollmentInfo":113,"targetDuration":4,"studyType":115,"phases":4,"briefSummary":116,"conditions":117,"keywords":122,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":42},"100602907","remote-monitoring-of-asthma-in-children-and-young-people-100602907","NCT07129616","Remote Monitoring of Asthma in Children and Young People","Remote Monitoring of Asthma in Children and Young People - Reducing Risk of Asthma Attack Using a Connected Patient Approach","Inclusion Criteria:\n\n* Children and Young People with a diagnosis of asthma (coded as asthma or suspected asthma) or a prescription of inhaled corticosteroid in the prior 2 years.\n\nExclusion Criteria:\n\n* Alternative non-asthma diagnosis that would require inhaled steroid\n* cystic fibrosis\n* bronchiectasis\n* primary ciliary dyskinaesia","5 Years","17 Years",{"count":114,"type":19},900,"OBSERVATIONAL","The objective of this study is to determine whether healthcare data and remotely collected patient data can accurately predict asthma attacks in children and young people aged 5-17 years. The main outcome is:\n\nwhen using this new system, is there a reduction in asthma attacks compared with a historic average.\n\nThe whole population of children and young people with asthma will have routine healthcare data monitored, with a subset of people with high risk asthma asked to participate in a more detail study involving remotely monitored data.",[118,119,27,120,121],"Asthma Childhood","Asthma Attack","Risk Assessment","Machine Learning",[123,124],"asthma attack risk reduction","remote monitoring","2026-01-20",{"date":127,"type":34},"2026-01-22",{"date":129,"type":34},"2025-11-20",{"date":131,"type":19},"2027-03-01",{"name":133,"class":41},"University of Edinburgh",{"id":135,"slug":136,"hasResults":11,"nctId":137,"briefTitle":138,"officialTitle":138,"acronym":4,"eligibilityCriteria":139,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":140,"targetDuration":4,"studyType":20,"phases":142,"briefSummary":143,"conditions":144,"keywords":4,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":151,"lastUpdatePostDateStruct":152,"startDateStruct":154,"completionDateStruct":156,"leadSponsor":158,"locationsCount":42},"100601030","feasibility-of-wireless-continuous-vital-sign-monitoring-and-impact-on-patients-undergoing-adult-spinal-surgery-in-a-general-ward-100601030","NCT07105189","Feasibility of Wireless Continuous Vital Sign Monitoring and Impact on Patients Undergoing Adult Spinal Surgery in a General Ward","Inclusion Criteria:\n\n* Included are adult patients (\\>=18 years) scheduled for ASD surgery with estimated a \\>3 day expected post-operative stay. ASD-surgery is defined as a posterior instrumented fusion of at least five spinal levels including instrumentation to the pelvis, caused by a degenerative condition of the spine.\n* Registered nurses and nurses' assistants employed at the orthopedic ward during the study period will be included if they have experience working with wCVSM during the study period. The study includes both sexes, variation of level of education and years of work experience. Included nurses and nurses' assistants should be proficient in the Danish language.\n\nExclusion Criteria:\n\n* Exclusion criteria are patients who are unable to wear continuous monitoring due to a pacemaker or allergy.\n* Patients who are not proficient in the Danish language will be excluded.",{"count":141,"type":19},150,[22],"The goal of this feasibility study is to explore the use of wireless continuous vital sign monitoring in an orthopaedic setting among orthopaedic nurses and patients undergoing adult spinal deformity surgery. In addition to the standard care National Early Warning Score the participants in this study will be monitored by CPC12S a wearable sensor that is worn on the chest using electrodes measuring electrocardiography single lead (ECG), Heart rate, respiratory rate, SpO2, blood pressure and temperature.\n\nMain hypotheses:\n\nThe use of wireless continuous vital sign monitoring in daily clinical practice for patients undergoing ASD surgery is feasible in terms of increased acceptability among orthopeadic surgical nurses measured over 12 months with a response rate of at least 80% with an average score of ≥5 at the last measurement in each of the four dimensions of the USE questionnaire: Usefulness, ease of use, ease of learning and satisfaction.\n\nThe following parameters will be evaluated:\n\nPrimary outcome:\n\n1. The feasibility in terms of acceptability of the concept of wCVSM among orthopedic surgical ward nurses.\n\n   Secondary outcomes:\n2. The feasibility in terms of acceptability of the concept of wCVSM in patients undergoing ASD surgery.\n3. The technical fidelity of wCVSM, assessed by data collected of vital signs, display of alerts to staff nurses and response to the alerts.\n4. The frequency of vital sign deviations in patients after ASD surgery using wCVSM compared to NEWS2.\n5. Clinical outcomes of patients undergoing ASD surgery including surgical complications, reinterventions, ICU admissions, unplanned ward transfer, and admissions to another department.",[145,146,147,148,149,27,150],"Adult Spinal Deformity","Wireless Continuous Vital Signs Monitoring","Wireless Vital Signs Monitoring System","Acceptability","ASD Surgery","Feasibility Studies","2026-01-06",{"date":153,"type":34},"2026-01-08",{"date":155,"type":34},"2025-12-10",{"date":157,"type":19},"2026-08-30",{"name":159,"class":41},"Rigshospitalet, Denmark",{"id":161,"slug":162,"hasResults":11,"nctId":163,"briefTitle":164,"officialTitle":165,"acronym":166,"eligibilityCriteria":167,"healthyVolunteers":168,"sex":169,"minAge":16,"maxAge":4,"enrollmentInfo":170,"targetDuration":4,"studyType":20,"phases":172,"briefSummary":173,"conditions":174,"keywords":177,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":197,"lastUpdatePostDateStruct":198,"startDateStruct":200,"completionDateStruct":202,"leadSponsor":204,"locationsCount":42},"100582120","feasibility-of-remote-ectg-monitoring-homehospital-in-complicated-pregnancies-100582120","NCT06859177","Feasibility of Remote eCTG Monitoring Home@Hospital in Complicated Pregnancies","Remote Electrophysiological Cardiotocography (eCTG), Evaluation of Feasibility in (a Selected Group of) Complicated Pregnancies From 32 Until 37 Weeks Gestational Age in a Home@Hospital Setting: a Prospective Cohort Study","HASTA","Inclusion Criteria:\n\nIn order to be eligible to participate in this study, a subject must meet all of the following criteria:\n\n* Minimum age of 18 years old\n* Pregnant patients with a gestational age between 32+0 and 36+6 weeks and days\n* Singleton pregnancy\n* Any indication for fetal monitoring at least twice per week (e.g.):\n\n  * Pre-eclampsia (PE)\n  * Fetal growth restriction (FGR)\n  * Preterm pre-labor rupture of membranes (PPROM)\n* Absence of exclusion criteria \\> 24 hours after admission.\n* Oral and written informed consent is obtained.\n\nExclusion Criteria:\n\nA potential subject who meets any of the following criteria will be excluded from participation in this study:\n\n* An indication for intravenous medication\n* Blood pressure \\>160\u002F110 A millimeter of mercury (mmHg)\n* Absent-\u002For reversed flow umbilical artery Doppler\n* Hemolysis Elevated Liver enzymes and Low Platelets (HELLP) (Table 1)\n* Obstetric intervention expected \\\u003C48 hours, e.g. due to:\n\n  * Non reassuring cardiotocography (CTG)\n  * Active vaginal blood loss\n  * Signs of abruption placentae\n  * Meconium stained amniotic fluid\n  * Signs of chorioamnionitis\n* Patients admitted with a clinical diagnosis of sepsis with hypotension (i.e. septic shock).\n* Insufficient knowledge of Dutch or English language\n* Insufficient comprehension of instruction Nemo Remote® or patient information\n* Fetal and\u002For maternal cardiac arrhythmias\n* Contraindications to abdominal patch placement (dermatologic diseases of the abdomen precluding preparation of the abdomen with abrasive paper)\n* Patients connected to an external or implanted electrical stimulator, such as Transcutaneous Electro Neuro Stimulation (TENS) and pacemaker (because of disturbance of the electrophysiological signal).",true,"FEMALE",{"count":171,"type":19},60,[22],"The objective of this single center, interventional cohort study is to evaluate the feasibility of remote electrophysiological cardiotocography (eCTG) monitoring in complicated pregnancies in a home@hospital setting.\n\nThe primary objective is to assess:\n\n• The success rate of the self-administered eCTG measurement\n\nThe secondary objective is to asses:\n\n* Maternal and perinatal outcomes\n* Patients wellbeing and satisfaction.\n* Healthcare professionals' (HCPs') satisfaction\n* Analysis of antenatal costs\n\nParticipants will:\n\n* Self-administer remote eCTG monitoring once daily during admission (or at least twice weekly at the outpatient clinic)\n* Self-measure their blood pressure, heartrate and temperature\n* Enter the measurements, symptoms and worries into an application on their telephone.\n* Answer questionnaires at 3 moments during the study, assessing their wellbeing and satisfaction of the received care and self-administered remote monitoring device.",[175,27,176],"Pregnancy Related","Feasibility",[178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,124,194,195,196],"feasibility","remote","complicated pregnancies","antenatal","Non invasive fetal electrocardiography (NI-fECG)","electrophysiological cardiotocography (eCTG)","high-risk pregnancies","pregnancy","maternal and fetal monitoring","monitoring","electrophysiological","non invasive","preterm pre-labor rupture of membranes (PPROM)","pre-eclampsia (PE)","fetal growth restriction (FGR)","home monitoring","second trimester","self-administered","satisfaction","2025-09-23",{"date":199,"type":34},"2025-09-26",{"date":201,"type":34},"2025-03-25",{"date":203,"type":19},"2026-12",{"name":205,"class":41},"Maxima Medical Center",{"id":207,"slug":208,"hasResults":11,"nctId":209,"briefTitle":210,"officialTitle":211,"acronym":4,"eligibilityCriteria":212,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":213,"targetDuration":4,"studyType":20,"phases":215,"briefSummary":216,"conditions":217,"keywords":220,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":224,"lastUpdatePostDateStruct":225,"startDateStruct":227,"completionDateStruct":229,"leadSponsor":231,"locationsCount":42},"100603791","self-monitoring-and-remote-monitoring-of-chronic-pain-in-primary-care---using-a-digital-tool-to-improve-quality-of-life-100603791","NCT07141108","Self-monitoring and Remote Monitoring of Chronic Pain in Primary Care - Using a Digital Tool to Improve Quality of Life","Egenmonitorering Och Distansmonitorering av långvarig smärta i primärvården, användandet av Ett Digitalt Verktyg för Att ökad livskvalité","Inclusion Criteria:\n\nHas pain that affects daily life and has lasted for more than 3 months\n\nIs over 18 years old\n\nUnderstands Swedish or English\n\nIs motivated and willing to use a digital tool for self-monitoring of activity level and symptoms\n\nHas no planned surgeries during the study period\n\nHas knowledge of and access to using a smartphone or tablet\n\nExclusion Criteria:\n\nSevere or acute mental illness, severe anxiety, or depression\n\nOngoing history of substance use disorder\n\nSerious illness under active treatment\n\nPain related to malignancy\n\nCurrently involved in legal proceedings or ongoing litigation related to low back or neck pain\n\n\\-",{"count":214,"type":19},30,[22],"Chronic pain impacts individuals, their families, and society significantly, yet specialist care resources are limited, with most patients managed in primary care. There is a need for tools that support self-management and improve resource allocation. This feasibility study evaluates the implementation of Paindrainer®, a CE-marked Class I digital tool, in primary care. Paindrainer® combines patient self-monitoring via an app with a healthcare provider portal (CARE) for remote monitoring. Using advanced neural networks, it offers personalized feedback to help patients plan and monitor daily activities and their impact on pain. The study aims to assess whether integrating this tool can enhance chronic pain management and patient quality of life.",[218,219,27],"Persistent Pain","Pain Management",[221,222,223],"chronic pain","pain management","persistent pain","2025-08-18",{"date":226,"type":34},"2025-08-26",{"date":228,"type":34},"2025-05-14",{"date":230,"type":19},"2026-03-31",{"name":232,"class":41},"Lund University",{"id":234,"slug":235,"hasResults":11,"nctId":236,"briefTitle":237,"officialTitle":238,"acronym":239,"eligibilityCriteria":240,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":241,"targetDuration":4,"studyType":115,"phases":4,"briefSummary":242,"conditions":243,"keywords":245,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":247,"lastUpdatePostDateStruct":248,"startDateStruct":250,"completionDateStruct":252,"leadSponsor":254,"locationsCount":42},"100561219","remote-assessment-of-signs-and-symptoms-in-palliative-care-100561219","NCT06587321","Remote Assessment of Signs and Symptoms in Palliative Care","The ReASSure-PC Study: A Feasibility Study of Remote Assessment of Signs and Symptoms in Palliative Care","ReASSure-PC","Inclusion Criteria:\n\n* Primary diagnosis of advanced cancer or another life-limiting condition\n* Estimated prognosis greater than 3 months\n* Referred for community-based specialist palliative care\n* Living in own home (or home of family carer)\n* Living with a family carer\n\nExclusion Criteria:\n\n* Estimated prognosis less than 3 months or more than 12 months\n* Cognitive impairment - unable to provide consent \u002F complete assessments\n* Non-English speaker\n* Living in care home \u002F nursing home \u002F hospice \u002F community hospital\n* Not living with a family carer",{"count":214,"type":19},"Digital health interventions, including remote monitoring of patients, have been identified as a possible way to address current problems within the health service, including insufficient numbers of staff, and an increasing number of patients requiring services.\n\nThe aim of this study is to assess the feasibility of using remote monitoring for patients who are receiving palliative care and to see whether remote monitoring can improve care and outcomes for patients and their families.\n\nParticipants in this study will complete regular (daily, weekly, monthly) questionnaires online about how they are feeling. They will also be given equipment to measure their vital signs every day. The clinical team will have access to the results and be able to respond to any new problems as they arise. Patients and their carers will then complete a questionnaire at one month to assess satisfaction with the use of remote monitoring.",[26,244,27],"Vital Signs",[246],"Remote monitoring","2025-06-23",{"date":249,"type":34},"2025-06-27",{"date":251,"type":34},"2024-04-01",{"date":253,"type":19},"2025-08-31",{"name":255,"class":41},"Our Lady's Hospice and Care Services",{"id":257,"slug":258,"hasResults":11,"nctId":259,"briefTitle":260,"officialTitle":260,"acronym":261,"eligibilityCriteria":262,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":263,"targetDuration":4,"studyType":115,"phases":4,"briefSummary":265,"conditions":266,"keywords":4,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":268,"lastUpdatePostDateStruct":269,"startDateStruct":271,"completionDateStruct":273,"leadSponsor":275,"locationsCount":278},"100451945","clinical-assessment-of-essential-remote-monitoring-functions-in-pacemakers-100451945","NCT05165095","Clinical Assessment of Essential Remote Monitoring Functions in Pacemakers","CALLIOPE","Inclusion Criteria:\n\n1. Patient implanted according to the most recent guidelines from the ESC, for 20 days or less (de novo implantation, device upgrade to dual chamber or device replacement)\n2. Patient implanted with an ALIZEA, BOREA or CELEA dual chamber pacemaker from MicroPort CRM\n3. Patient implanted with any active or passive CE marked bipolar RA lead, and any active or passive CE marked bipolar RV lead\n4. Patient's pacemaker with the remote monitoring functions (i.e. the RAAT, the RVAT and the remote alerts) accepted by the patient and planned to be activated\n5. Patient reviewed, signed and dated the ICF\n\nExclusion Criteria:\n\n1. Patient with an elevated RV pacing threshold (strictly above 2.0 V for a pulse width of 0.5 ms or below)\n2. Patient with permanent AF\n3. Patient already enrolled in another clinical investigation that could confound the results of this clinical investigation (e.g., clinical investigations involving intra-cardiac device)\n4. Patient implanted despite a contraindication for cardiac pacing system implantation (i.e. patient implanted with a defibrillator, patient contraindicated for a single dose of 310 μg of dexamethasone sodium phosphate, patient implanted with a tricuspid replacement heart valve or with a significant tricuspid valve disease that may lead to future replacement heart valve surgery)\n5. Minor age patient (i.e. under 18 years of age)\n6. Incapacitated patient, under guardianship, kept in detention, refusing to cooperate or not able to understand the purpose of this clinical investigation\n7. Patient unavailable for the follow-up visits scheduled\n8. Non-menopausal women",{"count":264,"type":19},206,"The purpose of the clinical investigation is to document the safety and the performances of the remote monitoring functions of the ALIZEA, BOREA and CELEA pacemakers, i.e. the RAAT, the RVAT and the remote alerts.",[267,27],"Bradycardia","2024-05-30",{"date":270,"type":34},"2024-05-31",{"date":272,"type":34},"2022-03-25",{"date":274,"type":19},"2027-07",{"name":276,"class":277},"MicroPort CRM","INDUSTRY",19]